Novo Integrated Sciences, Inc. (NVOS) vs Syra Health Corp. (SYRA)
Novo Integrated Sciences, Inc. and Syra Health Corp. are both Medical Care Facilities companies. Syra Health Corp. is the larger, with a market value of $1.1M against $730.0K — 1.5× the size. Novo Integrated Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Syra Health Corp. trades at 90.0×. Novo Integrated Sciences, Inc. grew revenue faster over the last twelve months: 5.75% against 0.32%. Syra Health Corp. has the higher net margin (1.62% vs −121.6%) and the higher return on invested capital (9.15% vs −42.4%). Across the 15 metrics below, Syra Health Corp. leads on 11 and Novo Integrated Sciences, Inc. on 4.
Valuation
Profitability
| Metric | NVOS | SYRA | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | 43.19% | 39.35% | 30.78% |
| Operating margin | (75.79%) | 0.92% | 5.74% |
| Net margin | (121.61%) | 1.62% | 2.32% |
| Free cash flow margin | (38.54%) | 1.36% | 5.46% |
| Return on equity | (82.67%) | 5.18% | 8.76% |
| Return on assets | (47.76%) | 3.58% | 2.18% |
| Return on invested capital | (42.44%) | 9.15% | 5.40% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack